SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF

Wanda Christ; Sebastian Kapell; Georgios Mermelekas; Bjorn Evertsson; Helena Sork; Safa Bazaz; Oskar Gustafsson; Michal J. Sobkowiak; Eduardo I. Cardenas; Viviana Villa; Roberta Ricciarelli; Johan K Sandberg; Jonas Bergquist; Andrea Sturchio; Per Svenningsson; Tarja Malm; Alberto J. Espay; Maria Pernemalm; Anders Linden; Jonas Klingstrom; Samir EL Andaloussi; Kariem Ezzat.
Preprint em Inglês | PREPRINT-BIORXIV | ID: ppbiorxiv-508120

Documentos relacionados

  1. The Inhibition of DNA Viruses by the Amphibian Antimicrobial Peptide Temporin G: A Virological Study Addressing HSV-1 and JPCyV.
  2. Individual herpes simplex virus 1 (HSV-1) particles exit by exocytosis and accumulate at preferential egress sites.
  3. New model integrates innate responses, PML-NB formation, epigenetic control and reactivation from latency.
  4. Suicidal Phenotype of Proofreading-Deficient Herpes Simplex Virus 1 Polymerase Mutants.
  5. Mouse Mx1 Inhibits Herpes Simplex Virus Type 1 Genomic Replication and Late Gene Expression <i>In Vitro</i> and Prevents Lesion Formation in the Mouse Zosteriform Model.
  6. Manipulation of Oxidative Stress Responses by Non-Thermal Plasma to Treat Herpes Simplex Virus Type 1 Infection and Disease.
  7. Identification and characterisation of SARS-CoV-2 and Human alphaherpesvirus 1 from a productive coinfection in a fatal COVID-19 case.
  8. The ATP-Dependent RNA Helicase DDX3X Modulates Herpes Simplex Virus 1 Gene Expression.
  9. Instantaneous Inactivation of Herpes Simplex Virus by Silicon Nitride Bioceramics.
  10. The propagation of HSV-1 in high autophagic activity.